Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction | NEJM
Original Article from The New England Journal of Medicine — Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction
Related Articles
ChatGPT to the rescue?
For years, but especially since the pandemic, this page and many others in Science and elsewhere have been filled with lamentations about the spread of…
Durably reducing conspiracy beliefs through dialogues with AI
Conspiracy theory beliefs are notoriously persistent. Influential hypotheses propose that they fulfill important psychological needs, thus resisting counterevidence. Yet previous failures in correcting conspiracy beliefs…
Spending for Common Oral Cancer Medications After the Inflation Reduction Act
This economic evaluation assesses changes to patient out-of-pocket spending for oral cancer medications before and after the Inflation Reduction Act.
Fibrotic response to anti-CSF-1R therapy potentiates glioblastoma recurrence
Watson et al. show that multiple modes of therapy-induced glioblastoma regression are associated with fibrosis, which promotes tumor cell survival. Using multi-omics analyses, they identify the…
Breast cancer rises among Asian American and Pacific Islander women
Christina Kashiwada was traveling for work during the summer of 2018 when she noticed a small, itchy lump in her left breast.
New study reveals major pathway releasing ‘forever chemicals’ at concerning rate: ‘Definitely an alarming thing for us to see’
Scientists have discovered that PFAS, a group of human-made chemicals, are being released as gases from landfills at alarming rates.
This 70-year-old med student just graduated. He has this advice for others | CNN
Everyone thought he was the professor. But the gray-haired older man was a freshman medical student — just like the rest of the class.
Immune landscape of oncohistone-mutant gliomas reveals diverse myeloid populations and tumor-promoting function
Nature Communications – Histone H3-mutant gliomas are deadly brain tumours and the tumour microenvironment is not fully understood. Here the authors profile the immune microenvironment…
TGF-β and RAS jointly unmask primed enhancers to drive metastasis
During carcinoma metastasis, malignant progenitors undergo a TGF-β-dependent EMT associated with fibroblast activation and extracellular matrix remodeling in the tumor microenvironment. RAS-activated RREB1 primes enhancers…
Sex-dependent effects in the aged melanoma tumor microenvironment influence invasion and resistance to targeted therapy
Aging-driven and sex-dependent molecular changes in skin fibroblasts drive the emergence of invasive and therapy-resistant melanomas in male mice.